Quốc gia: Hoa Kỳ
Ngôn ngữ: Tiếng Anh
Nguồn: NLM (National Library of Medicine)
TAMSULOSIN HYDROCHLORIDE (UNII: 11SV1951MR) (TAMSULOSIN - UNII:G3P28OML5I)
RedPharm Drug, Inc.
ORAL
PRESCRIPTION DRUG
Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies ( 14)]. Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. Tamsulosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to tamsulosin hydrochloride or any component of tamsulosin hydrochloride capsules. Reactions have included skin rash, urticaria, pruritus, angioedema, and respiratory symptoms [see Adverse Reactions ( 6.2)]. Risk Summary Tamsulosin hydrochloride is not indicated for use in women. There are no adequate data on the developmental risk associated with the use of tamsulosin hydrochloride in pregnant women. No adverse developmental effects were observed in animal studies in which tamsulosin hydrochloride was administered to rats or rabbits during the period of organogenesis (GD 7 to 17 in the rat and GD 6 to 18 in the rabbit) [see Data]. In
Tamsulosin hydrochloride capsules, USP are comprising of olive green opaque cap imprinted “CL 23", and orange opaque body imprinted "0.4" in black ink. Tamsulosin hydrochloride capsules, USP 0.4 mg are supplied as below: Bottle of 30 capsules NDC 33342-159-07 Bottle of 100 capsules NDC 33342-159-11 Bottle of 500 capsules NDC 33342-159-15 Bottle of 1000 capsules NDC 33342-159-44 Unit dose package of 100 capsules NDC 33342-159-12 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep tamsulosin hydrochloride capsules and all medicines out of reach of children.
Abbreviated New Drug Application
TAMSULOSIN HYDROCHLORIDE- TAMSULOSIN HYDROCHLORIDE CAPSULE REDPHARM DRUG, INC. ---------- TAMSULOSIN 0.4MG 1 INDICATIONS & USAGE Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) _[see Clinical Studies ( 14)]. _Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. 2 DOSAGE & ADMINISTRATION Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened. For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of Tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole) _[see Warnings and Precautions ( 5.2)]. _ If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose. 3 DOSAGE FORMS & STRENGTHS Tamsulosin hydrochloride capsule, USP: 0.4 mg, olive green opaque cap imprinted “CL 23” and orange opaque body imprinted "0.4" in black ink. 4 CONTRAINDICATIONS Tamsulosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to tamsulosin hydrochloride or any component of tamsulosin hydrochloride capsules. Reactions have included skin rash, urticaria, pruritus, angioedema, and respiratory symptoms _[see Adverse Reactions ( 6.2)]._ 5 WARNINGS AND PRECAUTIONS 5.1 ORTHOSTASIS The signs and symptoms of orthostasis (postural hypotension, dizziness, and vertigo) were detected more frequently in tamsulosin hydrochloride capsule-treated patients than in placebo recipients. As with other alpha adrenergic blocking agents there is a potential ri Đọc toàn bộ tài liệu